Trusted Press Release Distribution   Join | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Precision Business Insights
www.precisionbusinessinsights.com
Rajesh k
sales@precisionbusinessinsights.com
Precision Business Insights, Kemp House, 152 – 160 City Road,
EC1V 2NX

Bookmark and Share
Global Plaque Psoriasis Treatment Market To Be Valued US$ 20,388.2 Mn by 2023
Global Plaque Psoriasis Treatment Market To Be Valued US$ 20,388.2 Mn by 2023


Plaque Psoriasis Treat...
BriefingWire.com, 5/17/2018 - Global Plaque Psoriasis Treatment Market To Be Valued US$ 20,388.2 Mn by 2023

The Global Plaque Psoriasis Treatment Market poised to reach USD 20,388.2 Million by 2023 with a significant CAGR over the forecast period (2018-2023) owing to increase in prevalence of the psoriasis conditions all across the globe”

Precision Business Insights (PBI) in its report titled “Global Plaque Psoriasis Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2023” assesses the market performance over six years forecast period. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The global plaque psoriasis treatment market was valued at USD 11,411.7 Million in 2017 and projected to reach USD 20,388.2 Million by 2023 owing to increase in the prevalence of the psoriasis conditions all across the globe. Increase in awareness about the psoriasis conditions and active participation of non-profit organizations to bring awareness among the psoriasis patients about the new therapies are expected to drive the plaque psoriasis market.

Free sample of this report is available upon request @

www.precisionbusinessinsights.com/market-reports/plaque-psoriasis-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

Global Plaque Psoriasis Treatment market segmented on the basis of product type, route of administration, distribution channel, and country

Interleukin Inhibitors accounted for higher revenue share

Based on product type global plaque psoriasis treatment market segmented into Interleukin Inhibitors, Tumor Necrosis Factor (TNF), and others. Interleukin Inhibitors expected to account a significant revenue share in global plaque psoriasis treatment market with share of 32.4% (2018) in global market and projected to grow at 20.0% CAGR over 2018 and 2023.

North America leads the Global Plaque Psoriasis Treatment market

Free TOC of this report is available upon request @

www.precisionbusinessinsights.com/market-reports/plaque-psoriasis-treatment-market/#ulp-c654SbFYO64MsOhu

Global plaque psoriasis treatment market report further reveals that the key players increasingly adopting strategies such as licensing agreements, partnerships & collaboration to improve market revenue share and gaining significant geographic presence across the region. For instance In July 2017, Almirall and Sun Pharma has entered into a license agreement on the development and commercialization of tildrakizumab for psoriasis in Europe. Under terms of the license agreement, Sun Pharma will be eligible to receive development and regulatory milestone payments and, additionally, sales milestone payments and royalties on net sales.

Need more information about this report @

www.precisionbusinessinsights.com/market-reports/plaque-psoriasis-treatment-market/#ulp-14mlyhjMGhVjZqa3

Detailed Segmentation

By Product Type

• Interleukin Inhibitors

? Tildrakizumab

? Guselkumab

? Ixekizumab

? Secukinumab

? Ustekinumab

? Brodalumab

• Tumor Necrosis Factor (TNF)

? Etanercept

? Adalimumab

? Infliximab

• Others

Get access to full summary @

www.precisionbusinessinsights.com/market-reports/plaque-psoriasis-treatment-market/

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2013 Proserve Technology, Inc.